Literature DB >> 6795663

Alcohol induced discoordination is not reversed by naloxone.

D M Catley, C Jordan, C D Frith, J R Lehane, A M Rhodes, J G Jones.   

Abstract

It has previously been reported that prior administration of naloxone may prevent the decrement in performance produced by alcohol. To be clinical value, however, naloxone must be shown to reverse rather than prevent this decrement. This study examined the effect of naloxone given after consumption of alcohol. A double blind balanced crossover protocol was used to examine the effect of either 1.2 mg or 10 mg naloxone on the sensory-motor impairment produced by blood alcohol concentrations maintained between 75 and 85 mg/100 ml. This alcohol concentration significantly impaired two measures of sensory-motor performance, but there was no evidence that either dose of naloxone could reverse this decrement. We tested our subjects for a chlorpropamide alcohol flush but none gave a positive response. These results indicate that naloxone (1.2 mg or 10 mg) does not reverse the sensory-motor impairment produced by alcohol intoxication in subjects who do not exhibit a chlorpropamide alcohol flush. Nearly all the subjects exhibited somnolence after receiving alcohol and naloxone (1.2 mg or 10 mg) but not after receiving alcohol and saline.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6795663     DOI: 10.1007/BF00433504

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  12 in total

1.  Selective action of alcohols on cerebral calcium levels.

Authors:  D H Ross
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

2.  Prevention of effects of alcohol intoxication by naloxone.

Authors:  W J Jeffcoate; M Herbert; M H Cullen; A G Hastings; C P Walder
Journal:  Lancet       Date:  1979-12-01       Impact factor: 79.321

3.  Learning rhythmic hand movements.

Authors:  C D Frith
Journal:  Q J Exp Psychol       Date:  1973-05       Impact factor: 2.143

4.  A simple mechanical ataxia-meter.

Authors:  B M Wright
Journal:  J Physiol       Date:  1971-10       Impact factor: 5.182

5.  Reversal of ethanol-induced coma with naloxone.

Authors:  D B Jefferys; R J Flanagan; G N Volans
Journal:  Lancet       Date:  1980-02-09       Impact factor: 79.321

6.  Naloxone in alcohol intoxication.

Authors:  A I Mackenzie
Journal:  Lancet       Date:  1979-03-31       Impact factor: 79.321

7.  Naloxone as an antagonist in severe alcohol intoxication.

Authors:  S C Sørensen; K Mattisson
Journal:  Lancet       Date:  1978-09-23       Impact factor: 79.321

8.  Learning and reminiscence as a function of target predictability in a two-dimensional tracking task.

Authors:  C D Frith; R J Lang
Journal:  Q J Exp Psychol       Date:  1979-02       Impact factor: 2.143

9.  Chlorpropamide-alcohol flushing: a dominantly inherited trait associated with diabetes.

Authors:  R D Leslie; D A Pyke
Journal:  Br Med J       Date:  1978-12-02

10.  The human pharmacology and abuse potential of N-allylnoroxymorphone (naloxone).

Authors:  D R Jasinski; W R Martin; C A Haertzen
Journal:  J Pharmacol Exp Ther       Date:  1967-08       Impact factor: 4.030

View more
  4 in total

1.  Antagonism of the stimulant and depressant effects of ethanol in rats by naloxone.

Authors:  M Prunell; J Boada; M Feria; M A Benitez
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  Ethanol and tetrahydroisoquinoline alkaloids do not produce narcotic discriminative stimulus effects.

Authors:  G T Shearman; A Herz
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

Review 3.  New and experimental therapeutic roles for naloxone and related opioid antagonists.

Authors:  L F McNicholas; W R Martin
Journal:  Drugs       Date:  1984-01       Impact factor: 9.546

4.  Antagonism of the behavioral effects of ethanol by naltrexone in BALB/c, C57BL/6, and DBA/2 mice.

Authors:  K Kiianmaa; P L Hoffman; B Tabakoff
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.